Bronchodilators and Theophylline NCLEX Questions With Rationales
What it is
Bronchodilators are medications that relax airway smooth muscle and improve airflow in clients with obstructive respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). They include beta-2 agonists, anticholinergics, and methylxanthines such as theophylline. Inhaled corticosteroids are anti-inflammatory controller medications frequently used with bronchodilators to maintain asthma control.
What the NCLEX focuses on
- Albuterol is a short-acting beta-2 agonist (SABA) that rapidly relaxes bronchial smooth muscle and is used for quick relief of bronchospasm when prescribed.
- Common albuterol adverse effects include tachycardia, palpitations, tremors, nervousness, and sometimes hypokalemia, particularly with frequent or high-dose administration.
- Increasing rescue inhaler use, nighttime symptoms, or reduced response to albuterol suggests inadequate asthma control and requires provider reassessment.
- Long-acting beta-2 agonists (LABAs), such as salmeterol, must not be used alone for asthma because LABA monotherapy increases the risk of serious asthma-related outcomes. They should be prescribed with inhaled corticosteroid therapy.
- Anticholinergic bronchodilators include ipratropium, a short-acting agent, and tiotropium, a long-acting agent. They reduce bronchoconstriction by blocking muscarinic receptors and may cause dry mouth, blurred vision, and urinary retention.
- Inhaled corticosteroids, such as budesonide and fluticasone, reduce airway inflammation and prevent exacerbations but do not provide immediate relief during an acute asthma attack.
- Clients should rinse their mouth with water and spit after using an inhaled corticosteroid to reduce oral candidiasis and throat irritation.
- When separate bronchodilator and inhaled corticosteroid inhalers are prescribed, the bronchodilator is generally administered first to open the airways and improve delivery of the corticosteroid.
- Theophylline is a methylxanthine bronchodilator with a narrow therapeutic margin. Toxicity may cause nausea, vomiting, tremors, tachycardia, dysrhythmias, and potentially life-threatening seizures.
Priority nursing actions
- Assess respiratory rate, oxygen saturation, breath sounds, work of breathing, cough, wheezing, and ability to speak before administering respiratory medications.
- Administer prescribed rescue bronchodilators promptly for acute bronchospasm and reassess respiratory status and response to treatment.
- Monitor heart rate, rhythm, tremors, and potassium when frequent or high-dose beta-2 agonist treatment is administered.
- Review medication technique and adherence, and report increasing rescue inhaler requirements or worsening respiratory symptoms to the provider.
- Monitor theophylline serum concentrations and assess for nausea, persistent vomiting, tachycardia, tremors, dysrhythmias, and seizures. With suspected toxicity, hold further doses according to protocol and notify the provider immediately.
- Review medication interactions and changes in smoking habits because ciprofloxacin and cimetidine may increase theophylline concentrations, while smoking increases its clearance. Changes in smoking status require reassessment.
Numbers to know
| Value | Number | Why it matters |
|---|---|---|
| Theophylline therapeutic range | 10 to 20 mcg/mL; current labeling notes most benefit at 10 to 15 | Current U.S. labeling identifies this range as providing most therapeutic benefit while minimizing serious adverse effects. |
| Theophylline concentration associated with increased toxicity | Greater than 20 mcg/mL | Persistent vomiting, cardiac arrhythmias, and seizures become more likely. |
| SABA use requiring reassessment | More than 2 days per week | Frequent rescue medication use, excluding prevention of exercise-induced symptoms, may indicate inadequate asthma control. |
| Peak flow green zone | 80 to 100% of personal best | Indicates generally good asthma control. |
| Peak flow yellow zone | 50 to 79% of personal best | Indicates worsening asthma and the need to follow the written action plan. |
| Peak flow red zone | Less than 50% of personal best | Indicates a medical alert requiring immediate action according to the asthma action plan. |
Common exam traps
- Choosing an inhaled corticosteroid as the only immediate treatment for acute bronchospasm: wrong because corticosteroids reduce inflammation but do not provide rapid bronchodilation.
- Choosing LABA monotherapy for asthma: wrong because LABAs must be used with inhaled corticosteroid treatment.
- Choosing to administer an inhaled corticosteroid before a separately prescribed bronchodilator: wrong because the bronchodilator is generally administered first.
- Choosing to ignore nausea, vomiting, and tachycardia in a client taking theophylline: wrong because these findings may indicate medication toxicity.
- Choosing to stop theophylline monitoring when a client stops smoking: wrong because smoking cessation decreases theophylline clearance and may increase serum concentrations.
What to teach
- Teach clients to distinguish rescue medications from daily controller medications and follow their individualized asthma action plan.
- Demonstrate metered-dose inhaler technique: shake the inhaler if required, exhale, seal the lips around the mouthpiece or spacer, actuate while inhaling slowly and deeply, and hold the breath briefly. Follow device-specific instructions.
- Explain that a spacer improves medication delivery from a metered-dose inhaler and reduces medication deposition in the mouth and throat.
- Teach clients to rinse and spit after inhaled corticosteroid use and to report persistent white patches or mouth soreness.
- Instruct clients taking theophylline to avoid unapproved medication changes, report new prescriptions, and discuss caffeine intake and smoking changes with the healthcare provider.
- Teach clients how to use a peak flow meter consistently and record results according to their written asthma action plan.
2 NCLEX questions with rationales on this topic
From the NCLEXPace question bank. Choose your answer first, then open the correct answer and the full rationale under each question.
A client with asthma reports using the albuterol inhaler 8 times in the past day, more than the usual prescribed amount, to control wheezing. Which action should the nurse take?
Select the best answer.
- A. Assess respiratory status and notify the provider urgently; this suggests an exacerbation and poor control
- B. Reassure the client that frequent albuterol use is acceptable during a bad asthma day as long as each dose provides at least temporary relief
- C. Stop using albuterol for the rest of the day and use extra doses of inhaled fluticasone whenever wheezing returns to reduce airway inflammation
- D. Explain that needing albuterol this often can happen during temporary symptom flares and continue the current regimen unless the inhaler stops providing relief
Show the correct answer and rationale
Correct answer:
- A. Assess respiratory status and notify the provider urgently; this suggests an exacerbation and poor control
Rationale
Overview
- Definition: Albuterol use for symptoms more than 2 days/week indicates inadequate asthma symptom control; repeated use above the prescription in one day indicates urgent exacerbation risk.
- Signs and symptoms: Increasing wheeze, shortness of breath, restricted speech, accessory muscle use, and reduced peak flow indicate worsening airflow obstruction.
- Response: Prompt severity assessment guides urgent treatment.
Nursing key points
- Assess respiratory rate, work of breathing, wheeze, speech, oxygen saturation, and peak flow.
- Compare peak flow with personal best; below 50% indicates severe airflow limitation.
- Activate emergency care for severe distress, a silent chest, or altered consciousness.
- Notify the provider urgently; anticipate prescribed acute treatment, including systemic corticosteroids when indicated.
- Review controller adherence and technique after stabilization; monitor albuterol-related tremor and tachycardia.
Answer analysis
| Nursing action | Rationale |
|---|---|
| Assess respiratory status and notify the provider urgently; this suggests an exacerbation and poor control | Correct. Excessive reliever use requires immediate assessment and urgent treatment review. |
| Reassure the client that frequent albuterol use is acceptable during a bad asthma day as long as each dose provides at least temporary relief | Not correct. Temporary relief does not establish adequate control. |
| Stop using albuterol for the rest of the day and use extra doses of inhaled fluticasone whenever wheezing returns to reduce airway inflammation | Not correct. Fluticasone alone does not relieve acute bronchospasm. |
| Explain that needing albuterol this often can happen during temporary symptom flares and continue the current regimen unless the inhaler stops providing relief | Not correct. Waiting delays necessary escalation. |
A client taking theophylline reports nausea, a fast heart rate, and a fine tremor after starting a new medication and increasing coffee intake. Which action should the nurse take?
Select the best answer.
- A. Tell the client to stop theophylline permanently and use the other inhalers
- B. Reassure the client that these are caffeine effects and need no testing
- C. Report the findings and anticipate a theophylline level being checked
- D. Increase coffee intake for alertness while continuing the usual dose
Show the correct answer and rationale
Correct answer:
- C. Report the findings and anticipate a theophylline level being checked
Rationale
Overview
- Definition: Theophylline toxicity results from excessive drug exposure in a medication with a narrow therapeutic range.
- Signs: Nausea, vomiting, tachycardia, tremor, and insomnia precede severe dysrhythmias and seizures.
- Interactions: Ciprofloxacin, erythromycin, cimetidine, and fluvoxamine reduce clearance through metabolic inhibition. Caffeine adds stimulant effects.
Nursing key points
- Report this symptom cluster promptly and obtain urgent prescribing guidance.
- Withhold further doses pending evaluation according to orders or protocol.
- Anticipate a serum theophylline concentration; document formulation and last dose time.
- Compare results with the prescribed target, often 5 to 15 mcg/mL; toxicity also occurs within therapeutic concentrations.
- Review new medications and caffeine intake; seek emergency care for seizures or severe palpitations.
Answer analysis
| Nursing action | Rationale |
|---|---|
| Tell the client to stop theophylline permanently and use the other inhalers | Not correct. Temporary withholding and assessment precede a prescriber-directed long-term decision. |
| Reassure the client that these are caffeine effects and need no testing | Not correct. These findings require evaluation for toxicity. |
| Report the findings and anticipate a theophylline level being checked | Correct. Serum testing and interaction review guide treatment. |
| Increase coffee intake for alertness while continuing the usual dose | Not correct. Additional caffeine worsens stimulant effects. |
The NCLEXPace bank has 3,200+ NCLEX questions with full rationales, sorted by topic, with your progress tracked as you practice. Create your account to start.
Create Account →More topics in Pharmacology
Proton Pump Inhibitors and Antacids NCLEX Questions With RationalesReviews acid-suppressing medications, administration, adverse effects, drug interactions, and nursing priorities for gastrointestinal bleeding.Calcium Channel Blockers NCLEX Questions With RationalesReviews calcium channel blocker classes, cardiovascular uses, adverse effects, nursing assessments, medication safety, and client teaching.Statins NCLEX Questions With RationalesReviews statin medications, LDL reduction, adverse effects, drug interactions, laboratory monitoring, and client education.Sources
- National Heart, Lung, and Blood Institute. Asthma Care Quick Reference. 2012.
- National Heart, Lung, and Blood Institute. Monitoring Your Asthma. 2020.
- National Library of Medicine, DailyMed. Theophylline Extended-Release Tablets: Prescribing Information. 2025.
- National Library of Medicine, DailyMed. Tiotropium Bromide Inhalation Spray: Prescribing Information. 2025.
3,200+ NCLEX questions with think-like-a-nurse rationales, unfolding case studies and adaptive readiness exams. Start with free practice questions, then choose a plan when you are ready.
Create Account →